Tharun is a Chartered Financial Analyst from the CFA Institute, U.S. A graduate from Loyola College, Chennai, he started his career in Goldman Sachs at their Bangalore office. Prior to his current role at Proactive Investors, he worked as an equity analyst at a global research and analytics company in Mumbai, assisting institutional clients across Asia.
First time that Cellmid has recorded quarterly sales above $2 million.
The company's ‘million-dollar day’ sale in Japan was successful.
On track for a pilot cannabis growing program targeted for first half of 2018.
Initial products imported to Australia will include cannabidiol oil.
An important step towards the commercialisation of ResAppDx in the U.S.
The company is preparing to start a pilot cannabis growing program.
The company already manufactures and distributes hemp-based products in the U.S.
The federal government is planning to allow the export of medicinal cannabis products from Australia.